摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

hexahydro-1,1,4,4a,9,10,10a 2H-phenanthrenone-3 | 85617-29-4

中文名称
——
中文别名
——
英文名称
hexahydro-1,1,4,4a,9,10,10a 2H-phenanthrenone-3
英文别名
1,4,4a,9,10,10a-hexahydro-2H-phenanthren-3-one;1,4,4a,9,10,10a-Hexahydro-2H-phenanthren-3-on;2,4,4a,9,10,10a-hexahydro-1H-phenanthren-3-one
hexahydro-1,1,4,4a,9,10,10a 2H-phenanthrenone-3化学式
CAS
85617-29-4
化学式
C14H16O
mdl
——
分子量
200.28
InChiKey
WKTBCMMWVPTNMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    hexahydro-1,1,4,4a,9,10,10a 2H-phenanthrenone-3 生成 trans-1,2,3,4,4a,9,10,10a-octahydrophenanthren-3-one
    参考文献:
    名称:
    BANSAL, ROMESH C.;BROWNE, CLINTON E.;EISENBRAUN, EDMUND J.;THOMSON, JANE +, J. ORG. CHEM., 53,(1988) N 2, 452-455
    摘要:
    DOI:
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 盐酸溶剂黄146 作用下, 生成 hexahydro-1,1,4,4a,9,10,10a 2H-phenanthrenone-3
    参考文献:
    名称:
    3-Ketohydrophenanthrenes and 2′-Ketohydro-1,2-cyclopentenonaphthalenes
    摘要:
    DOI:
    10.1021/ja01178a060
点击查看最新优质反应信息

文献信息

  • [EN] MODULATORS OF THE GLUCOCORTICOID RECEPTOR<br/>[FR] MODULATEURS DU RECEPTEUR GLUCOCORTICOIDE
    申请人:PFIZER PROD INC
    公开号:WO2004005229A1
    公开(公告)日:2004-01-15
    The present invention provides compounds of the formula wherein A is of the formula and X, Y, n, R1-R25 are as described in the specification which are modulators of the glucocorticoid receptor and are thus useful for the treatment of animals requiring glucocorticoid receptor ágonist.therapy. Glucocorticoid-receptor modulators are useful in the treatment of certain inflammatory conditions.
    本发明提供了以下式中A为该式,X、Y、n、R1-R25如说明书中所述的化合物,这些化合物是糖皮质激素受体的调节剂,因此对需要糖皮质激素受体激动剂治疗的动物有用。糖皮质激素受体调节剂在治疗某些炎症性疾病中是有用的。
  • LOW MOLECULAR WEIGHT MODULATORS OF THE COLD MENTHOL RECEPTOR TRPM8 AND USE THEREOF
    申请人:BASF SE
    公开号:US20170265510A1
    公开(公告)日:2017-09-21
    The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.
    本发明涉及新型的冷薄荷感受受体TRPM8的调制剂,以及利用这些调制剂调节TRPM8受体的方法;特别是利用这些调制剂诱导寒冷感觉的用途;以及利用这些调制剂生产的文章和组合物。
  • Reactivite des β-cyclopropyl α-enones—I
    作者:R Jullien、H Stahl-Lariviere、D Zann、L Nadjo
    DOI:10.1016/s0040-4020(01)98848-9
    日期:1981.1
    Species produced by electron transfer to variously substituted bicyclo[3.1.0]hex-3-en-2-ones provide a better insight into the origin of 1,6-addition products sometimes observed by reaction of lithium diorganocuprates with β-cyclopropyl α-enones. Cyclic voltammetry of eight such bicyclohexenones show that the half-lives of the corresponding anion radicals are very short (t12⩽10−4s) except when the
    通过电子转移至各种取代的双环[3.1.0] hex-3-en-2-ones产生的物种,使人们更深入地了解了有时通过二有机十二酸锂与β-环丙基α-的反应观察到的1,6-加成产物的起源。烯酮。的八个这样bicyclohexenones循环伏安法显示,对应的阴离子自由基的半衰期非常短(T 12 ⩽10 -4 S)除了当初始分子是在C-4取代的苯基。在这种情况下,阴离子自由基非常稳定(t 12s6s)由于更大的电荷离域而引起,我们观察到第二波对应于Dianion的形成。液态氨中的溶剂化电子还原相同的底物表现出相同的行为差异。产生强反应性阴离子基团的分子仅会产生共轭还原所预期的直接产物;反之亦然。而4-苯基取代的底物则产生正常共轭还原和重排产物的混合物。这种相关性强烈表明,这些最后的产物是由二价阴离子的重排产生的。
  • 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives
    申请人:F. HOFFMANN-LA ROCHE AG
    公开号:EP0921125A1
    公开(公告)日:1999-06-09
    The present invention relates to compounds of the general formula wherein R1is hydrogen, lower alkyl, halogen, lower alkoxy, trifluoromethyl, lower alkyl-phenyl or (C5-7)-cycloalkyl; R2is hydrogen, lower alkyl, phenyl or lower alkyl-phenyl; R3is hydrogen, lower alkyl, benzyl, lower alkyl-phenyl, lower alkyl-diphenyl, triazinyl, cyanomethyl, lower alkyl-piperidinyl, lower alkyl-naphthyl, (C5-7)-cycloalkyl, lower alkyl-(C5-7)-cycloalkyl, lower alkyl-pyridinyl, lower alkyl-morpholinyl, lower alkyl-dioxolanyl, lower alkyl-oxazolyl or lower alkyl-2-oxo-oxazolidinyl and wherein the ring systems may be substituted by additional lower alkyl, lower alkoxy, trifluoromethyl or phenyl, or -(CH2)nC(O)O-lower alkyl, -(CH2)nC(O)NH2, -(CH2)nC(O)N(lower alkyl)2, -(CH2)nOH or -(CH2)nC(O)NHCH2C6H5; R4is hydrogen, lower alkyl or nitrilo; Ais a ring system, consisting of (a) (C5-15)-cycloalkyl, which may be in addition to R4optionally substituted by lower alkyl, trifluoromethyl, phenyl, (C5-7)-cycloalkyl, spiro-undecan-alkyl or by 2-norbornyl, or is one of the following groups dodecahydro-acenaphthylen-1yl (e), bicyclo[6.2.0]dec-9-yl (f) and bicyclononan-9-yl (g); and wherein R5 and R6are hydrogen, lower alkyl or taken together and with the carbon atoms to which they are attached form a phenyl ring; R7is hydrogen or lower alkyl; the dotted line represents an optional bond and nis 1 to 4; and to pharmaceutically acceptable acid addition salts thereof. Compounds of the present invention are agonists and/or antagonists of the Orphanin FQ (OFQ) receptor. Consequently they will be useful in the treatment of memory and attention deficits, psychiatric, neurological and physiological disorders, especially, but not limited to, amelioration of symptoms of anxiety and stress disorders, depression, trauma, memory loss due to Alzheimer's disease or other dementias, epilepsy and convulsions, acute and/or chronic pain conditions, symptoms of addictive drug withdrawal, control of water balance, Na+ excretion, arterial blood pressure disorders and metabolic disorders such as obesity.
    本发明涉及通式如下的化合物 式中 R1是氢、低级烷基、卤素、低级烷氧基、三氟甲基、低级烷基苯基或(C5-7)-环烷基; R2 是氢、低级烷基、苯基或低级烷基苯基; R3是氢、低级烷基、苄基、低级烷基-苯基、低级烷基-二苯基、三嗪基、氰甲基、低级烷基-哌啶基、低级烷基-萘基、(C5-7)-环烷基、低级烷基-(C5-7)-环烷基、低级烷基-吡啶基、低级烷基-吗啉基、低级烷基-二氧戊环基、低级烷基-噁唑基或低级烷基-2-氧代-噁唑烷基,其中环系统可被额外的低级烷基、低级烷氧基、三氟甲基或苯基取代,或被-(CH2)nC(O)O-低级烷基、-(CH2)nC(O)NH2、-(CH2)nC(O)N(低级烷基)2、-(CH2)nOH 或 -(CH2)nC(O)NHCH2C6H5取代; R4 是氢、低级烷基或硝基; A 是一个环状系统,包括 (a) (C5-15)-环烷基,除 R4 外,还可被低级烷基、三氟甲基、苯基、(C5-7)-环 烷基、螺十一烷基或 2-降冰片基取代,或为以下基团之一 十二氢-苊烯-1-基 (e)、双环[6.2.0]癸-9-基 (f) 和双环壬-9-基 (g); 其中 R5 和 R6 为氢、低级烷基或与它们所连接的碳原子一起形成苯环; R7 为氢或低级烷基; 虚线代表任选键,且 n为 1 至 4; 及其药学上可接受的酸加成盐。 本发明的化合物是孤儿素 FQ(OFQ)受体的激动剂和/或拮抗剂。因此,它们可用于治疗记忆和注意力缺陷、精神、神经和生理疾病,特别是但不限于改善焦虑和应激障碍、抑郁症、创伤、阿尔茨海默病或其他痴呆症引起的记忆丧失、癫痫和抽搐、急性和/或慢性疼痛、成瘾药物戒断症状、控制水平衡、Na+排泄、动脉血压紊乱和代谢紊乱(如肥胖)等症状。
  • Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof
    申请人:BASF SE
    公开号:US10398159B2
    公开(公告)日:2019-09-03
    The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.
    本发明涉及新型的冷薄荷受体 TRPM8 调节剂,使用这些调节剂调节 TRPM8 受体的方法;特别是使用这些调节剂诱导冷感;以及使用这些调节剂生产的物品和组合物。
查看更多